Maze Therapeutics, Inc.
Maze Therapeutics, Inc. (MAZE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
maze · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$97.00
Consensus
$63.25
+168.2% upside
Low
$46.00
Median: $55 · Last Close: $23.58
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$63.25
168.2% upside
High Target
$97
311.4%
Low Target
$46
95.1%
Current Price
$23.58
as of today
Based on analyst price targets, the MAZE stock price prediction for the next 12 months ranges from $46 to $97. The consensus MAZE price forecast of $63.25 implies 168.2% upside from the current price of $23.58.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $22.82 | ↓ 3.22% |
1-day model range: $22.68–$22.96. Peak: $22.96 (-3.22%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MAZE · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-14 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-31 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-25 | BTIG | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-09 | BTIG | Maintains | Buy→Buy |
| 2026-03-04 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-16 | BTIG | Maintains | Buy→Buy |
| 2025-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-07 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Maze Therapeutics, Inc. (MAZE) stock. Of the recent 17 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover MAZE.
Analyst Recommendation Trends
MAZE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$20M
↑ 87.4% YoY
Revenue Next Year
$14M
↓ 30.5% YoY
EPS This Year
$-2.75
EPS Next Year
$-3.22
↑ 17.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast MAZE EPS of $-2.75 for the current fiscal year, based on estimates from 7 analysts. The MAZE revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MAZE stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MAZE price target is $63.25 (+168.2% upside), with an analyst consensus of Buy.
The MAZE short-term stock prediction for tomorrow is $22.82 (-3.22%).
Maze Therapeutics, Inc. trades on NASDAQ under the ticker MAZE. The MAZE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
MAZE forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month MAZE price target is $63.25, with a high forecast of $97.00 and a low of $46.00. The median price target is shown in the chart above when available. This implies +168.2% potential upside from the current price of $23.58.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.